QCM
CRL icon

Quantinno Capital Management’s Charles River Laboratories CRL Stock Holding History

Quantinno Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49M Sell
216,150
-10,919
-5% -$1.94M 0.06% 401
2026
Q1 		$39.2M Sell
227,069
-22,746
-9% -$4.22M 0.07% 364
2025
Q4 		$49.8M Buy
249,815
+4,237
+2% +$769K 0.1% 198
2025
Q3 		$38.4M Buy
245,578
+89,493
+57% +$14.2M 0.1% 207
2025
Q2 		$23.7M Buy
156,085
+38,286
+33% +$5.11M 0.1% 211
2025
Q1 		$17.7M Buy
117,799
+80,869
+219% +$13.6M 0.12% 182
2024
Q4 		$6.82M Buy
36,930
+16,224
+78% +$3.13M 0.07% 346
2024
Q3 		$4.08M Buy
20,706
+4,516
+28% +$939K 0.05% 450
2024
Q2 		$3.34M Sell
16,190
-641
-4% -$145K 0.06% 391
2024
Q1 		$4.56M Buy
16,831
+124
+0.7% +$29.6K 0.1% 217
2023
Q4 		$3.95M Sell
16,707
-184
-1% -$36.2K 0.14% 159
2023
Q3 		$3.31M Buy
16,891
+5,829
+53% +$1.2M 0.15% 141
2023
Q2 		$2.33M Buy
11,062
+8,696
+368% +$1.73M 0.13% 191
2023
Q1 		$478K Buy
+2,366
New +$536K 0.03% 595

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Quantinno Capital Management's CRL Position: Q2 2026 in Review

Quantinno Capital Management reduced its Charles River Laboratories (CRL) stake by 4.8% in Q2 2026, selling an estimated $1.94M and leaving 216,150 shares worth $49M. The position accounts for 0.06% of the portfolio, ranked #401.

Quantinno Capital Management first reported a position in CRL in Q1 2023 and has held it in 14 quarters since. The position peaked at $49.8M in Q4 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Quantinno Capital Management held 216,150 shares of Charles River Laboratories worth $49M as of Q2 2026.
  • Quantinno Capital Management sold 10,919 Charles River Laboratories shares in Q2 2026, an estimated $1.94M.
  • Charles River Laboratories made up 0.06% of Quantinno Capital Management's portfolio in Q2 2026, its #401 holding.
  • Quantinno Capital Management first reported a position in Charles River Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Quantinno Capital Management's Charles River Laboratories position peaked at $49.8M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.